期刊文献+

近期国内政策法规变动对仿制药研发和申报的影响 被引量:1

Impact of Recent Changes in Domestic Policies and Regulations on the Development and Application of Generic Drugs
下载PDF
导出
摘要 目的:探讨国内政策法规变动对仿制药开发和申报的影响。方法:通过整理近期出台的政策法规,分析其中与仿制药开发相关的政策变化,给予相应的开发建议。结果与结论:针对当前政策变化对仿制药开发带来的可能影响,提出一些建议,希望能给国内其他仿制药研发机构予以参考。 Objective: To explore the impact of recent changes in domestic policies and regulations on the development and appli- cation of generic drugs. Methods: Through the collation of the recent regulatory documents, the policy changes for generic drugs were analyzed, and the corresponding development proposals were provided. Results and Conclusion: According to the possible impact of current policy changes on generic drug development, the relative solutions are proposed with the aim to provide certain reference for ge- neric pharmaceutical R & D institutions.
作者 沈威 金燕芬 Shen Wei Jin Yanfen(Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. , Hangzhou 310011, China Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co. Ltd.)
出处 《中国药师》 CAS 2017年第2期321-324,共4页 China Pharmacist
关键词 仿制药 政策法规 备案 一致性评价 Generic drugs Policies and regulations Record Consistency evaluation
  • 相关文献

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部